Display options
Cite
Maumus M, Rozier P, Boulestreau J, et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation. Front Bioeng Biotechnol. 2020;8:997doi: 10.3389/fbioe.2020.00997.
Maumus, M., Rozier, P., Boulestreau, J., Jorgensen, C., & Noël, D. (2020). Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation. Frontiers in bioengineering and biotechnology, 8997. https://doi.org/10.3389/fbioe.2020.00997
Maumus, Marie, et al. "Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation." Frontiers in bioengineering and biotechnology vol. 8 (2020): 997. doi: https://doi.org/10.3389/fbioe.2020.00997
Maumus M, Rozier P, Boulestreau J, Jorgensen C, Noël D. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation. Front Bioeng Biotechnol. 2020 Sep 10;8:997. doi: 10.3389/fbioe.2020.00997. eCollection 2020. PMID: 33015001; PMCID: PMC7511661.
Copy Download .nbib Format: NLM
Share it on

Front Bioeng Biotechnol. 2020 Sep 10;8:997. doi: 10.3389/fbioe.2020.00997. eCollection 2020.

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation.

Frontiers in bioengineering and biotechnology

Marie Maumus, Pauline Rozier, Jérémy Boulestreau, Christian Jorgensen, Danièle Noël

Affiliations

  1. IRMB, University of Montpellier, INSERM, CHU Montpellier, Montpellier, France.
  2. Bauerfeind France, IRMB, Montpellier, France.
  3. Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Department of Rheumatology, Lapeyronie University Hospital, Montpellier, France.

PMID: 33015001 PMCID: PMC7511661 DOI: 10.3389/fbioe.2020.00997

Abstract

Extracellular vesicles (EVs), including exosomes and microvesicles, derived from mesenchymal stem/stromal cells (MSCs) exert similar effects as their parental cells, and are of interest for various therapeutic applications. EVs can act through uptake by the target cells followed by release of their cargo inside the cytoplasm, or through interaction of membrane-bound ligands with receptors expressed on target cells to stimulate downstream intracellular pathways. EV-based therapeutics may be directly used as substitutes of intact cells or after modification for targeted drug delivery. However, for the development of EV-based therapeutics, several production, isolation, and characterization requirements have to be met and the quality of the final product has to be tested before its clinical implementation. In this review, we discuss the challenges associated with the development of EV-based therapeutics and the regulatory specifications for their successful clinical translation.

Copyright © 2020 Maumus, Rozier, Boulestreau, Jorgensen and Noël.

Keywords: clinical translation; extracellular vesicles; mesenchymal stem cells; regenerative medicine; therapy

References

  1. Gene. 2020 Aug 15;751:144764 - PubMed
  2. Int J Pharm. 2017 Mar 30;520(1-2):86-97 - PubMed
  3. Biomater Sci. 2019 Dec 17;8(1):39-63 - PubMed
  4. Stem Cell Res Ther. 2019 Sep 23;10(1):288 - PubMed
  5. ACS Omega. 2019 Dec 19;4(27):22638-22645 - PubMed
  6. JCI Insight. 2018 Apr 19;3(8): - PubMed
  7. Front Bioeng Biotechnol. 2019 Nov 05;7:308 - PubMed
  8. Front Cell Dev Biol. 2016 Aug 22;4:83 - PubMed
  9. Vet Immunol Immunopathol. 2019 Feb;208:6-15 - PubMed
  10. Ann Med. 2016;48(4):235-45 - PubMed
  11. Sci Rep. 2017 Mar 06;7:43923 - PubMed
  12. J Control Release. 2019 Sep 10;309:11-24 - PubMed
  13. Biochem Soc Trans. 2018 Aug 20;46(4):843-853 - PubMed
  14. J Cereb Blood Flow Metab. 2013 Nov;33(11):1711-5 - PubMed
  15. Aging (Albany NY). 2020 Jul 13;12(13):12669-12683 - PubMed
  16. Biochimie. 2013 Dec;95(12):2229-34 - PubMed
  17. Neurochem Res. 2020 Jan;45(1):204-214 - PubMed
  18. Expert Opin Biol Ther. 2015 Jan;15(1):103-17 - PubMed
  19. J Extracell Vesicles. 2015 Apr 20;4:26316 - PubMed
  20. J Transl Med. 2015 Sep 19;13:308 - PubMed
  21. Stem Cell Res. 2010 May;4(3):214-22 - PubMed
  22. Front Pharmacol. 2019 Nov 14;10:1368 - PubMed
  23. Stem Cells Transl Med. 2016 Jun;5(6):754-63 - PubMed
  24. Biomaterials. 2016 Oct;105:195-205 - PubMed
  25. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:125-154 - PubMed
  26. Life Sci. 2019 Sep 15;233:116733 - PubMed
  27. Trends Biotechnol. 2019 Jul;37(7):707-729 - PubMed
  28. J Cell Mol Med. 2017 Dec;21(12):3381-3393 - PubMed
  29. Stem Cell Res Ther. 2020 Jan 3;11(1):9 - PubMed
  30. Leukemia. 2014 Apr;28(4):970-3 - PubMed
  31. Food Chem Toxicol. 2002 Jul;40(7):871-98 - PubMed
  32. Bull Exp Biol Med. 2019 May;167(1):131-135 - PubMed
  33. Stem Cell Res Ther. 2019 Nov 28;10(1):359 - PubMed
  34. J Extracell Vesicles. 2015 Dec 31;4:30087 - PubMed
  35. Sci Rep. 2017 Jun 28;7(1):4323 - PubMed
  36. Front Pharmacol. 2018 Oct 29;9:1199 - PubMed
  37. Stem Cells. 2020 May;38(5):698-711 - PubMed
  38. Int J Biochem Cell Biol. 2018 Jul;100:49-53 - PubMed
  39. Nanomedicine (Lond). 2019 Mar;14(6):753-765 - PubMed
  40. Bioeng Transl Med. 2017 Jun 26;2(2):170-179 - PubMed
  41. J Trauma Acute Care Surg. 2020 Aug;89(2S Suppl 2):S100-S108 - PubMed
  42. Front Cell Dev Biol. 2020 Feb 21;8:107 - PubMed
  43. Cell Death Dis. 2018 Feb 13;9(2):218 - PubMed
  44. Arthritis Rheumatol. 2016 Apr;68(4):1013-25 - PubMed
  45. J Nutr. 1999 Jan;129(1):158-64 - PubMed
  46. Theranostics. 2018 Jan 1;8(1):237-255 - PubMed
  47. Int J Pharm. 2018 Dec 20;553(1-2):1-7 - PubMed
  48. Theranostics. 2018 Feb 3;8(5):1399-1410 - PubMed
  49. Stem Cell Rev Rep. 2018 Aug;14(4):484-499 - PubMed
  50. PLoS One. 2019 Dec 31;14(12):e0227283 - PubMed
  51. Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228 - PubMed
  52. Stem Cells. 2014 Jan;32(1):116-25 - PubMed
  53. Stem Cells Transl Med. 2015 Oct;4(10):1131-43 - PubMed
  54. AAPS J. 2017 Nov 27;20(1):1 - PubMed
  55. Front Cell Infect Microbiol. 2019 Apr 26;9:125 - PubMed
  56. Stem Cell Res Ther. 2020 Jan 3;11(1):13 - PubMed
  57. Clin Chem. 2002 Oct;48(10):1647-53 - PubMed
  58. J Extracell Vesicles. 2013 Dec 23;2: - PubMed
  59. Cytometry A. 2018 Jan;93(1):32-49 - PubMed
  60. Biotechnol J. 2019 Oct;14(10):e1800528 - PubMed
  61. Int J Mol Sci. 2017 Aug 16;18(8): - PubMed
  62. J Transl Med. 2011 Apr 25;9:47 - PubMed
  63. Stem Cells Dev. 2018 Apr 1;27(7):456-465 - PubMed
  64. J Biol Chem. 2017 Dec 22;292(51):20897-20910 - PubMed
  65. Front Pharmacol. 2019 Oct 11;10:1152 - PubMed
  66. Front Bioeng Biotechnol. 2020 Feb 14;8:90 - PubMed
  67. Cytotherapy. 2017 Apr;19(4):458-472 - PubMed
  68. Biomaterials. 2020 Feb;231:119675 - PubMed
  69. J Control Release. 2017 Sep 28;262:104-117 - PubMed
  70. J Extracell Vesicles. 2014 Dec 22;3:25465 - PubMed
  71. Stem Cells Int. 2016;2016:5029619 - PubMed
  72. J Mol Med (Berl). 2014 Apr;92(4):387-97 - PubMed
  73. Stem Cell Res Ther. 2020 Feb 19;11(1):70 - PubMed
  74. Expert Opin Biol Ther. 2016 Jul;16(7):859-71 - PubMed
  75. Int J Mol Sci. 2017 Jun 03;18(6): - PubMed
  76. Stem Cell Res Ther. 2019 Dec 17;10(1):393 - PubMed
  77. Stem Cell Res Ther. 2017 Jan 23;8(1):9 - PubMed
  78. Tissue Eng Part B Rev. 2012 Apr;18(2):101-15 - PubMed
  79. Theranostics. 2018 Nov 29;8(22):6163-6177 - PubMed
  80. J Cell Mol Med. 2018 Mar;22(3):1992-2000 - PubMed
  81. J Extracell Vesicles. 2018 Nov 23;7(1):1535750 - PubMed
  82. Stem Cell Res Ther. 2014 Jun 10;5(3):76 - PubMed
  83. Am J Transl Res. 2018 Apr 15;10(4):1053-1070 - PubMed
  84. Stem Cell Res Ther. 2018 Mar 9;9(1):63 - PubMed
  85. Transl Res. 2019 Aug;210:80-98 - PubMed
  86. Stem Cells Dev. 2013 Mar 15;22(6):845-54 - PubMed
  87. J Transl Med. 2016 Feb 02;14:34 - PubMed
  88. Stem Cells. 2014 May;32(5):1074-82 - PubMed
  89. Sci Rep. 2017 Nov 24;7(1):16214 - PubMed
  90. Am J Respir Crit Care Med. 2015 Aug 1;192(3):324-36 - PubMed
  91. Front Physiol. 2019 Mar 19;10:282 - PubMed
  92. Cytotherapy. 2019 Jun;21(6):581-592 - PubMed
  93. Cells. 2018 Oct 30;7(11): - PubMed
  94. Aging (Albany NY). 2019 Sep 29;11(18):7996-8014 - PubMed
  95. Int J Nanomedicine. 2019 Jul 24;14:5679-5690 - PubMed
  96. Stem Cell Res Ther. 2019 Mar 18;10(1):99 - PubMed
  97. BMB Rep. 2020 Feb;53(2):118-123 - PubMed
  98. Int J Nanomedicine. 2019 Nov 01;14:8603-8610 - PubMed
  99. Stem Cell Res Ther. 2015 Jul 01;6:127 - PubMed
  100. Brain Behav Immun. 2017 Feb;60:220-232 - PubMed
  101. Stem Cells. 2018 Mar;36(3):420-433 - PubMed
  102. Adv Drug Deliv Rev. 2019 Jan 1;138:247-258 - PubMed
  103. Sci Rep. 2016 Nov 08;6:36162 - PubMed
  104. J Am Soc Nephrol. 2009 May;20(5):1053-67 - PubMed
  105. FASEB J. 2018 Feb;32(2):654-668 - PubMed
  106. Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):E3536-E3545 - PubMed
  107. J Neurosurg. 2015 Apr;122(4):856-67 - PubMed
  108. J Clin Med. 2019 Nov 04;8(11): - PubMed
  109. World J Stem Cells. 2014 Nov 26;6(5):526-39 - PubMed
  110. Adv Colloid Interface Sci. 2009 Jan 30;145(1-2):1-22 - PubMed
  111. Front Immunol. 2017 Nov 24;8:1626 - PubMed
  112. Biomaterials. 2018 Jan;150:137-149 - PubMed
  113. Biomater Res. 2016 Aug 05;20:21 - PubMed
  114. PLoS One. 2013 Jul 08;8(7):e68451 - PubMed
  115. Cells. 2019 Aug 23;8(9): - PubMed
  116. Stem Cell Res Ther. 2018 Sep 26;9(1):247 - PubMed
  117. Stem Cell Res Ther. 2018 Feb 03;9(1):25 - PubMed

Publication Types